How existing technologies and approaches such as targeted AI deployment can help make prior authorization workflows more ...
In the first part of her interview with Pharmaceutical Executive, Sandra Coufal, MD, CEO of Toragen, explains why the HPV E5 ...
Accelerated approval of sonrotoclax establishes a targeted BCL2 option in post–BTK inhibitor relapsed/refractory mantle cell lymphoma, a setting with limited effective salvage therapies and poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results